Gallic acid improves the metformin effects on diabetic kidney disease in mice

References

• Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab. 2001;12(5):225–230.
   PubMed Web of Science ®Google Scholar
• Sowers JR. Diabetes mellitus and vascular disease. Hypertension. 2013;61(5):943–947.
   PubMed Web of Science ®Google Scholar
• Xie W, Burke B. Nuclear lamins and diabetes mellitus. STEMedicine. 2020;2(5):e73.
   Google Scholar
• Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: an overview. Avicenna J Med. 2020;10(4):174–188.
   PubMedGoogle Scholar
• Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 2020;21(17):6275.
   Web of Science ®Google Scholar
• Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586–1593.
   PubMed Web of Science ®Google Scholar
• Baker C, Retzik-Stahr C, Singh V, et al. Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab. 2021;12:2042018820980225.
   Web of Science ®Google Scholar
• Dludla PV, Silvestri S, Orlando P, et al. Exploring the comparative efficacy of metformin and resveratrol in the management of diabetes-associated complications: a systematic review of preclinical studies. Nutrients. 2020;12(3):739.
   Web of Science ®Google Scholar
• Figueiredo ID, Lima TFO, Inacio MD, et al. Lycopene improves the metformin effects on glycemic control and decreases biomarkers of glycoxidative stress in diabetic rats. Diabetes Metab. Syndr. Obes. 2020;13:3117–3135.
   PubMed Web of Science ®Google Scholar
• Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542–546.
   PubMed Web of Science ®Google Scholar
• Cao XJ, Wu R, Qian HY, et al. Metformin attenuates diabetic neuropathic pain via AMPK/NF-kappaB signaling pathway in dorsal root ganglion of diabetic rats. Brain Res. 2021;1772:147663.
   PubMed Web of Science ®Google Scholar
• Chung MM, Nicol CJ, Cheng YC, et al. Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. Exp Cell Res. 2017;352(1):75–83.
   PubMed Web of Science ®Google Scholar
• Joshi T, Singh AK, Haratipour P, et al. Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications. J Cell Physiol. 2019;234(10):17212–17231.
   PubMed Web of Science ®Google Scholar
• Coughlan KA, Valentine RJ, Ruderman NB, et al. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes. 2014;7:241–253.
   PubMedGoogle Scholar
• Entezari M, Hashemi D, Taheriazam A, et al. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation. Biomed Pharmacother. 2022;146:112563.
   PubMed Web of Science ®Google Scholar
• Garud MS, Kulkarni YA. Gallic acid attenuates type I diabetic nephropathy in rats. Chem. Biol. Interact. 2018;282:69–76.
   PubMed Web of Science ®Google Scholar
• Oboh G, Ogunbadejo MD, Ogunsuyi OB, et al. Can gallic acid potentiate the antihyperglycemic effect of acarbose and metformin? Evidence from streptozotocin-induced diabetic rat model. Arch Physiol Biochem. 2022;128(3):619–627.
   PubMed Web of Science ®Google Scholar
• de Oliveira LS, Thome GR, Lopes TF, et al. Effects of gallic acid on Delta – aminolevulinic dehydratase activity and in the biochemical, histological and oxidative stress parameters in the liver and kidney of diabetic rats. Biomed Pharmacother. 2016;84:1291–1299.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang X, Zhang C, et al. Berberine improves the protective effects of metformin on diabetic nephropathy in db/db mice through Trib1-dependent inhibiting inflammation. Pharm Res. 2021;38(11):1807–1820.
   PubMed Web of Science ®Google Scholar
• Li X, Xu Q, Wu Y, et al. A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma. Carcinogenesis. 2014;35(6):1362–1370.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57(6):1446–1454.
   PubMed Web of Science ®Google Scholar
• Vasavada N, Agarwal R. Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis. 2005;12(2):146–154.
   PubMed Web of Science ®Google Scholar
• Gao H, Wu H. Maslinic acid activates renal AMPK/SIRT1 signaling pathway and protects against diabetic nephropathy in mice. BMC Endocr. Disord. 2022;22(1):25.
   PubMed Web of Science ®Google Scholar
• Han YC, Tang SQ, Liu YT, et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 2021;12(10):925.
   PubMed Web of Science ®Google Scholar
• Furman BL. Streptozotocin-Induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 2015;70(5):47.
   PubMedGoogle Scholar
• Chang CJ, Wang PC, Huang TC, et al. Change in renal glomerular collagens and glomerular filtration Barrier-Related proteins in a dextran sulfate Sodium-Induced colitis mouse model. Int. J. Mol. Sci. 2019;20(6):1458.
   Web of Science ®Google Scholar
• Fang J, Yao X, Hou M, et al. ApoL1 induces kidney inflammation through RIG-I/NF-kappaB activation. Biochem Biophys Res Commun. 2020;527(2):466–473.
   PubMed Web of Science ®Google Scholar
• Stanton RC,. Role of glucose metabolism and mitochondrial function in diabetic kidney disease. Curr. Diab. Rep. 2021;21(2):6.
   PubMed Web of Science ®Google Scholar
• Mojadami S, Ahangarpour A, Mard SA, et al. Diabetic nephropathy induced by methylglyoxal: gallic acid regulates kidney microRNAs and glyoxalase1-Nrf2 in male mice. Arch Physiol Biochem. 2021:1–8. DOI:10.1080/13813455.2020.1857775
   PubMed Web of Science ®Google Scholar
• Ha H, Hwang IA, Park JH, et al. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract. 2008;82 Suppl 1(Suppl 1):S42–S45.
   PubMedGoogle Scholar
• Bondeva T, Wolf G. Reactive oxygen species in diabetic nephropathy: friend or foe? Nephrol Dial Transplant. 2014;29(11):1998–2003.
   PubMed Web of Science ®Google Scholar
• Kashihara N, Haruna Y, Kondeti VK, et al. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17(34):4256–4269.
   PubMed Web of Science ®Google Scholar
• Alhaider AA, Korashy HM, Sayed-Ahmed MM, et al. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact. 2011;192(3):233–242.
   PubMed Web of Science ®Google Scholar
• Meng T, Qin W, Liu B. SIRT1 antagonizes oxidative stress in diabetic vascular complication. Front Endocrinol (Lausanne). 2020;11:568861.
   PubMed Web of Science ®Google Scholar
• Ren H, Shao Y, Wu C, et al. Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Mol Cell Endocrinol. 2020;500:110628.
   PubMed Web of Science ®Google Scholar
• Li F, Chen Y, Li Y, et al. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-kappaB pathway. Eur J Pharmacol. 2020;886:173449.
   PubMed Web of Science ®Google Scholar
• Siddhi J, Sherkhane B, Kalavala AK, et al. Melatonin prevents diabetes-induced nephropathy by modulating the AMPK/SIRT1 axis: focus on autophagy and mitochondrial dysfunction. Cell Biol Int. 2022;46(12):2142–2157.
   PubMed Web of Science ®Google Scholar